These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38608846)

  • 1. Amenamevir for treating acyclovir-resistant or refractory herpes simplex virus infection in allogeneic hematopoietic stem cell transplantation recipients: Two case reports.
    Sallée L; Souchet L; Boutolleau D; Nguyen S
    Int J Antimicrob Agents; 2024 Jun; 63(6):107169. PubMed ID: 38608846
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors and outcomes of acyclovir-resistant herpes simplex virus infection among hematopoietic cell transplant recipients: case-case-control investigation.
    Patel D; Marchaim D; Marcus G; Gayathri R; Lephart PR; Lazarovitch T; Zaidenstein R; Chandrasekar P
    Clin Transplant; 2014 Jan; 28(1):1-5. PubMed ID: 24033498
    [No Abstract]   [Full Text] [Related]  

  • 3. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study.
    Ariza-Heredia EJ; Chemaly RF; Shahani LR; Jang Y; Champlin RE; Mulanovich VE
    Transpl Int; 2018 Jun; 31(6):639-648. PubMed ID: 29464765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
    Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion.
    Akahoshi Y; Kanda J; Ohno A; Komiya Y; Gomyo A; Hayakawa J; Harada N; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kimura SI; Kikuchi M; Nakasone H; Kako S; Shiraki K; Kanda Y
    J Infect Chemother; 2017 Jul; 23(7):485-487. PubMed ID: 28262533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
    Muluneh B; Dean A; Armistead P; Khan T
    J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.
    Ikawa Y; Fujiki T; Nishimura R; Noguchi K; Koshino E; Fujiki A; Fukuda M; Kuroda R; Mase S; Araki R; Maeba H; Shiraki K; Yachie A
    J Infect Chemother; 2019 Jan; 25(1):65-67. PubMed ID: 30064949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
    Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
    J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
    Chen Y; Scieux C; Garrait V; Socié G; Rocha V; Molina JM; Thouvenot D; Morfin F; Hocqueloux L; Garderet L; Espérou H; Sélimi F; Devergie A; Leleu G; Aymard M; Morinet F; Gluckman E; Ribaud P
    Clin Infect Dis; 2000 Oct; 31(4):927-35. PubMed ID: 11049772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus reactivation among hematopoietic stem cell transplant recipients: re-evaluating acyclovir dosage.
    Alsuhebany N; Alshehri B; Aldairem A; Aleissa MM; AlQahtani H; Albarqi K; Almotairi B; AlAmri M; Alanazi W; Alay S; Alahmari B; Alzahrani M
    Bone Marrow Transplant; 2024 Jul; 59(7):1043-1045. PubMed ID: 38627451
    [No Abstract]   [Full Text] [Related]  

  • 13. Case Commentary: "Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients" by Bosetti et al.
    Srinivasan K; Ho DY
    Antimicrob Agents Chemother; 2023 May; 67(5):e0027623. PubMed ID: 37014226
    [No Abstract]   [Full Text] [Related]  

  • 14. Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.
    Moses SE; Osborne W; Valappil M; Collin M; Lee D; Waugh S; Jackson G; Parry CM; Crowley B
    J Clin Virol; 2011 Oct; 52(2):67-9. PubMed ID: 21665532
    [No Abstract]   [Full Text] [Related]  

  • 15. Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients.
    Bosetti D; Bernardi C; Maulini M; Giannotti F; Mamez AC; Masouridi-Levrat S; Chalandon Y; Neofytos D
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0173222. PubMed ID: 36971558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
    Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections.
    Safrin S
    Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710
    [No Abstract]   [Full Text] [Related]  

  • 18. Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: risk factors and prognostic significance.
    Chakrabarti S; Pillay D; Ratcliffe D; Cane PA; Collingham KE; Milligan DW
    J Infect Dis; 2000 Jun; 181(6):2055-8. PubMed ID: 10837192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
    Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.